IPR Status Patent/Copyright/Trademark Secured in India/Abroad IPR Details
0409 NF 2003 US application No. 10/893531 PCT/1B04/02320 IN: 1328 DEL 2004
Application/Uses
Treatment of malaria
Salient Technical Features including Competing Features
Active against P. Falciparum and also a chloroquine resistant strain
Level/Scale of Development and test result summary
Efficacy established. Invention licensed to Shreya Life Sciences, Mumbai and is now under joint development.
Status of Commercialization, if any
Toxicity of clinical evaluation in progress
Major Raw Materials to be Utilized
Zn acetate, L-proline etc.